Leading the way to safer medication
 Crosscheck  Recommender

Ceritinib

Description

Ceritinib is an orally highly selective and potent ALK inhibitor. Ceritinib inhibits autophosphorylation of ALK, ALK-mediated phosphorylation of downstream signalling proteins and proliferation of ALK-dependent cancer cells both in vitro and in vivo.

Medicine classification

ATC Code
Title
Class
L01ED02
Ceritinib
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01ED Anaplastic lymphoma kinase (ALK) inhibitors

Medicines

Drug
Countries

Australia Austria Canada France Lithuania

Product monographs

Monograph
Type
Country
ZYKADIA Hard capsule
MPI, EU: SmPC